• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT MEDICAL FlexNav Delivery System; Aortic Valve, Prosthesis, Percutaneously Delivered

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT MEDICAL FlexNav Delivery System; Aortic Valve, Prosthesis, Percutaneously Delivered Back to Search Results
Model Number FNAV-DS-LG
Medical Device Problem Codes Difficult to Advance (2920); Material Deformation (2976)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/13/2026
Type of Reportable Event Malfunction
Event or Problem Description
It was reported that on (b)(6) 2026, a 29mm navitor vision valve was selected for implant using a large flexnav delivery system (ds).Access site was selected as femoral artery.During the procedure, the ds was attempted to pass through the femoral artery and at the end of the bifurcation of superior common iliac artery it was unable to be advanced.Following several attempts, the ds was removed from the patient's anatomy, and the external sheath was re-inserted.Upon inspection, the ds's valve capsule around the radiopaque marker bank was observed to be damaged and the transition between the marker band and radiopaque tip was rough and also damaged.A second 29mm, navitor vision valve was selected for implant using a large flexnav ds.A non-abbott balloon was used as a dilation.The system was introduced and attempted to advance but resulted without success.The case was decided to be aborted.The patient remained hemodynamically stable throughout the procedure and there was no clinically significant delay reported.The patient was in a stable condition and subsequently discharged.
 
Additional Manufacturer Narrative
The device will not be returned for evaluation, the device was reportedly discarded.Investigation is not yet complete.A follow-up report will be submitted with all additional relevant information.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FlexNav Delivery System
Common Device Name
Aortic Valve, Prosthesis, Percutaneously Delivered
Manufacturer (Section D)
ABBOTT MEDICAL
5050 nathan lane n
plymouth MN 55442
Manufacturer (Section G)
Abbott Medical Reg#3007113487
177 county road b east
st. paul MN 55117 -178
Manufacturer Contact
karen krouse
5050 nathan lane n
plymouth, MN 55442
+1(651)756-5400
MDR Report Key25413895
Report Number2135147-2026-03812
Device Sequence Number18507984
Product Code NPT
UDI-Device Identifier05415067031389
UDI-Public(01)05415067031389(17)270831(10)11036883
Combination Product (Y/N)N
Initial Reporter CountryAS
PMA/510(K) Number
P190023
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 08/07/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model NumberFNAV-DS-LG
Device Catalogue NumberFNAV-DS-LG
Device Lot Number11036883
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? No
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/13/2026
Supplement Date Received by Manufacturer07/31/2026
Initial Report FDA Received Date06/05/2026
Supplement Report FDA Received Date08/07/2026
Was Device Evaluated by Manufacturer? (Y/N) No
Date Device Manufactured09/09/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
NVRO-29; NVRO-29.
Patient Age80 YR
Patient SexFemale
-
-